SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward

  title={SARS-CoV-2 (COVID-19) Vaccine Development and Production: An Ethical Way Forward},
  author={Kenneth V. Iserson},
  journal={Cambridge Quarterly of Healthcare Ethics},
  pages={1 - 10}
  • K. Iserson
  • Published 5 June 2020
  • Medicine
  • Cambridge Quarterly of Healthcare Ethics
Abstract The world awaits a SARS-CoV-2 virus (i.e., COVID-19 disease) vaccine to keep the populace healthy, fully reopen their economies, and return their social and healthcare systems to “normal.” Vaccine safety and efficacy requires meticulous testing and oversight; this paper describes how despite grandiose public statements, the current vaccine development, testing, and production methods may prove to be ethically dubious, medically dangerous, and socially volatile. The basic moral concern… 
Covid-19, the anti-vaccine movement and immunization challenges in Brazil
It is possible that Brazil will face some challenges in achieving collective immunity due to the anti-vaccine movement and the main factors that lead the population not to believe in vaccines were the real interests of industry and politicians, lack of confidence in research, and the amount of false information that circulates massively on social media.
A review of vaccine effects on women in light of the COVID-19 pandemic
  • Wen-Han Chang
  • Medicine
    Taiwanese Journal of Obstetrics and Gynecology
  • 2020
Vaccine design and delivery approaches for COVID-19
Exploring Impacts to COVID-19 Herd Immunity Thresholds Under Demographic Heterogeneity that Lowers Vaccine Effectiveness
An age-structured Susceptible-Infectious-Recovered-type mathematical model is developed to investigate the impacts of unvaccinated subpopulations on herd immunity in the United States and identifies two types of undervaccination: age-related and behavior-related.
Willingness of Indonesian Public on The Vaccination Programme as an Effort to Prevent Covid-19
  • Herza Olivina
  • Medicine
    Muhammadiyah International Public Health and Medicine Proceeding
  • 2021
The results showed that quite a lot of Indonesian people are willing to receive vaccinations but the government still needs to provide information, knowledge, and education about vaccination programs by involving all parties, both directly and the media so that Indonesian people who refuse or receive vaccines have the same perception or views as people who are willing received the Covid-19 vaccine.
Willingness to Be Vaccinated against COVID-19 in Spain before the Start of Vaccination: A Cross-Sectional Study
Being male, older than 60, married, retired, with a high level of education, or with a leftist political inclination, could increase the probability of accepting the COVID-19 vaccine, and Disinformation and the lack of political consensus were the main sources of distrust.
Knowledge, attitudes, and willingness of adolescents towards coronavirus disease 2019 vaccine in Bangkok, Thailand
Assessment of knowledge, attitudes, and willingness of adolescents at Satit Prasarnmit International Programme in Bangkok revealed that attitude toward COVID-19 vaccine acts as a major predictive factor toward the willingness to vaccinate against COIDs19 vaccine.
Ethics of Vaccination in Childhood—A Framework Based on the Four Principles of Biomedical Ethics
This work aimed to apply a framework for ethical analysis of vaccination in childhood based on the four principles of biomedical ethics to provide a comprehensive and applicable model on how to address the ethical aspects of vaccination at both individual and societal levels.


The Equitable Distribution of COVID-19 Therapeutics and Vaccines.
Here is a proposal for global cooperation to ensure equitable distribution of vaccines and therapies for COViD-19, with a common global interest.
The clinical development process for a novel preventive vaccine: An overview
An overview on the development path of a novel vaccine candidate based on the expectations of various guidelines issued by the World Health Organization, the European Medicines Agency, and the United States Food and Drug Administration is given.
Unveiling ‘Warp Speed,’ the White House’s America-first push for a coronavirus vaccine
The project, vaguely described to date but likely to be formally announced by the White House in the coming days, will pick a diverse set of vaccine candidates and pour essentially limitless resources into unprecedented comparative studies in animals, fast-tracked human trials, and manufacturing.
Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
It was found that there was widespread agreement that LMIC HCS can be ethically acceptable, provided that they have a sound scientific rationale, are accepted by local communities and meet usual research ethics requirements.
Ethics and etiquette in an emergency vaccine trial. The orchestration of compliance
Clinical research is theorized from the perspective of participants in an Ebola vaccine trial by analysing the practices that contributed to very high compliance rates.
The online competition between pro- and anti-vaccination views
A map of the contention surrounding vaccines that has emerged from the global pool of around three billion Facebook users is provided, which reveals a multi-sided landscape of unprecedented intricacy that involves nearly 100 million individuals partitioned into highly dynamic, interconnected clusters across cities, countries, continents and languages.
The ethical challenge of infection-inducing challenge experiments.
  • F. Miller, C. Grady
  • Medicine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2001
An ethical framework is offered for evaluating infection-inducing challenge experiments, which focuses on the scientific and public health rationale for conducting these studies, the risks that they pose and the ways in which these risks can be minimized.
Challenge studies of human volunteers: ethical issues
It is concluded that the major ethical concern with challenge studies is that of risk of harm and that the fact that a study is a challenge study is not a wrong in itself.